
Fischer Medical Ventures Ltd. (FISCHER) 52 Week Low Streak: Second Straight Session With Fresh Low
Updated: 16 Oct 2026 • 10:23 am
Posted by:

Fischer Medical Ventures Ltd. has now set a fresh 52-week low for its second straight session, extending a repeated one-year low pattern rather than a one-day dip. Across the streak, the stock has moved 0.41%, and the latest trough stood at Rs 29.1 while the latest traded price was Rs 29.68 at 16 October 2026 at 10:22 AM IST. Univest data confirms the pattern, but it does not establish a company-specific cause for the continued decline.
The company’s market capitalisation stands at Rs 2,065.31 crore, so this is not a small move for the stock even though the percentage change across the streak is modest. For readers tracking Fischer Medical Ventures Ltd. 52 Week Low Streak, the key point is the repetition: a fresh yearly low on back-to-back sessions tells a different story from a single-session break. It signals that the weakness has persisted long enough to keep resetting the lower end of the range.
Fischer Medical Ventures Ltd. 52 Week Low Streak: Consecutive Low Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 29.68 |
| Previous Close | Rs 29.3 |
| Today's Move | +Rs 0.38 (+1.3%) |
| Open | Rs 30.11 |
| High | Rs 30.11 |
| Low | Rs 29.1 |
| Market Capitalisation | Rs 2,065.31 crore |
Fischer Medical Ventures Ltd. (FISCHER) traded at Rs 29.68 versus the previous close of Rs 29.3, a rise of 1.3%. The stock opened at Rs 30.11, reached a high of Rs 30.11, touched a low of Rs 29.1.
At 16 October 2026 at 10:22 AM IST, Fischer Medical Ventures Ltd. share price was Rs 29.68, up Rs 0.38 or 1.3% from the previous close of Rs 29.3. The stock opened at Rs 30.11, matched its high at Rs 30.11 and slipped to a low of Rs 29.1, which is also the fresh 52-week low. That places the latest traded price closer to the lower end of the day’s range than the opening level, even though it was above the session low when last quoted.
This Fischer Medical Ventures Ltd. 52 Week Low Streak needs to be read with the wider context of the repeated low, not just the intraday move. The stock’s market capitalisation of Rs 2,065.31 crore makes the decline relevant to investors who follow Fischer Medical Ventures Ltd. share price, Fischer Medical Ventures Ltd. stock news and Fischer Medical Ventures Ltd. stock performance on the NSE and BSE. The day’s higher quote does not change the fact that the stock still sits at a fresh yearly low for a second straight session.
What the Repeated 52-Week Lows Show
Fischer Medical Ventures Ltd. 52 Week Low Streak now shows a clear two-session pattern of new yearly lows. The key distinction is that the latest low at Rs 29.1 is not an isolated breach; it follows the prior session’s low and leaves the stock on a lower floor for the second day in a row. The cumulative change across the streak is 0.41%, which is the best way to track the full move rather than reading only the latest session.
For readers of Fischer Medical Ventures Ltd. stock analysis and Fischer Medical Ventures Ltd. fundamental analysis, the broader message is simple: the market has kept repricing the stock lower across consecutive sessions, but the numbers alone do not confirm why. That means the repeated break in Fischer Medical Ventures Ltd. share price should be treated as a confirmed price pattern, not as proof of a specific corporate trigger. The continued question is whether the next session holds above the latest low or resets the yearly trough again.
Fischer Medical Ventures Ltd. (FISCHER) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 2,065.31 crore |
| P/E Ratio | 68.64x |
| P/B Ratio | 4.4x |
| ROE | 9.38% |
| ROCE | 12.27% |
| EPS | Rs 0.43 |
| Book Value Per Share | Rs 6.67 |
| Dividend Yield | 0.17% |
Fischer Medical Ventures Ltd. (FISCHER) fundamental metrics show P/E 68.64x, P/B 4.4x, ROE 9.38%, ROCE 12.27%. These ratios show where the company stands today and are not a call to buy or sell.
Fischer Medical Ventures Ltd. has a market capitalisation of Rs 2,065.31 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 68.64x, P/B at 4.4x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 9.38% and ROCE of 12.27%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 0.43, book value per share of Rs 6.67, dividend yield of 0.17%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 22.34x, median ROE of 4.11%, median ROCE of 6.04%. Together they describe the fundamental backdrop without implying a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Trading |
| Industry | Trading |
| Benchmark Scope | same industry |
| Company P/E Ratio | 68.64x |
| Benchmark Median P/E | 22.34x |
| Benchmark Average P/E | 90.03x |
| Benchmark P/E Range | 0.14x to 3,047.85x |
| Company P/B Ratio | 4.4x |
| Benchmark Median P/B | 1.34x |
| Company ROE | 9.38% |
| Benchmark Median ROE | 4.11% |
| Company ROCE | 12.27% |
| Benchmark Median ROCE | 6.04% |
| Company Market Capitalisation | Rs 2,065.31 crore |
| Benchmark Median Market Cap | Rs 52.61 crore |
Fischer Medical Ventures Ltd. (FISCHER) operates in the Trading sector, within the Trading industry.
Fischer Medical Ventures Ltd. (FISCHER) has a P/E ratio of 68.64x, which is above the benchmark median of 22.34x, a difference of +207.25%. A P/E difference of this kind is a reference point rather than a recommendation.
Fischer Medical Ventures Ltd. (FISCHER) has a ROE of 9.38%, which is above the benchmark median of 4.11%, a difference of +128.22%. Fischer Medical Ventures Ltd. (FISCHER) has a ROCE of 12.27%, which is above the benchmark median of 6.04%, a difference of +103.15%.
Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Aayush Art And Bullion Ltd. | AAYUSHBULL | 2,003.14 | 253.83 | 32.96 | 13.89 | 18.85 |
| Khazanchi Jewellers Ltd. | KHAZANCHI | 1,785.74 | 17.49 | 5.14 | 32.45 | 34.79 |
| Creative Newtech Ltd. | CNL | 1,677.06 | 25 | 4.6 | 21.38 | 19.44 |
| Madhuveer Com 18 Network Ltd. | JOJO | 1,661.97 | 240.38 | 21.37 | -6.65 | -1.09 |
| Vintage Coffee & Beverages Ltd. | VINCOFE | 2,612.62 | 33.12 | 4.64 | 17.91 | 19.18 |
Fischer Medical Ventures Ltd. (FISCHER) has a P/E ratio of 68.64x compared with the displayed peer median of 33.12x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 9.38% compares with a peer median of 17.91% across the companies shown in the table. ROCE stood at 12.27% versus the displayed peer median of 19.18%, providing a capital-efficiency comparison. Fischer Medical Ventures Ltd. (FISCHER) has a market capitalisation of Rs 2,065.31 crore. Among the 5 peers shown, only 1 has a larger market capitalisation.
Why Investors Are Watching Fischer Medical Ventures Ltd.
- Fischer Medical Ventures Ltd. 52 Week Low Streak confirms a second straight session of new yearly lows.
- The cumulative move across the streak is 0.41%, which is the right figure to track rather than only the latest session.
- The latest low of Rs 29.1 is below the previous session’s floor, showing that the range has shifted lower again.
- Valuation remains high versus the sector median, with P/E at 68.64 and P/B at 4.4.
- Readers tracking Fischer Medical Ventures Ltd. stock performance will want to see whether the next session resets the low again or holds above Rs 29.1.
About Fischer Medical Ventures Ltd.
Fischer Medical Ventures Ltd. operates in the Trading sector and Trading industry, and the streak has made its business context more important for readers following Fischer Medical Ventures Ltd. share price today. The company’s market capitalisation stands at Rs 2,065.31 crore, placing it among the more valuable names in its peer set. For a stock in a repeated low phase, the business backdrop helps frame how the market is treating the current valuation.
The numbers show a company with positive ROE and ROCE, a moderate dividend yield and a high earnings multiple relative to the sector. That mix is why Fischer Medical Ventures Ltd. Fundamental Analysis remains relevant even when the price is under pressure. For investors reviewing Fischer Medical Ventures Ltd. stock news and Fischer Medical Ventures Ltd. stock analysis, the core issue is not the business label alone, but how that business is being priced through the ongoing streak.
Track Fischer Medical Ventures Ltd. Share Price on Univest
Use Fischer Medical Ventures Ltd. (FISCHER) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.
Track Fischer Medical Ventures Ltd. share price, market cap, valuation ratios and company updates on Univest to follow how the Fischer Medical Ventures Ltd. 52 Week Low Streak develops from here. The next session will matter because repeated lows can shift the reference point for Fischer Medical Ventures Ltd. stock performance quickly.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
What does Fischer Medical Ventures Ltd. 52 Week Low Streak mean?
Ans. It means Fischer Medical Ventures Ltd. has set a fresh 52-week low on consecutive trading sessions. In this case, the stock has done so for a second straight session, which shows a repeated decline rather than a one-off breach.
How many sessions has Fischer Medical Ventures Ltd. set a fresh 52-week low?
Ans. The stock has set a fresh 52-week low for its second straight session. That streak matters because it shows the lower range has been reset on back-to-back trading days. The stock moved 1.3% during the session.
By how much has Fischer Medical Ventures Ltd. moved across the streak?
Ans. The cumulative move across the streak is 0.41%. That is the most useful figure for this event because it captures the full repeated-low pattern instead of only the latest session’s change.
What is the latest 52-week low for Fischer Medical Ventures Ltd.?
Ans. The latest 52-week low is Rs 29.1. This level was also the day’s low in the latest session and marks the lower end of the repeated low pattern. The stock moved 1.3% during the session.
Is a company-specific cause confirmed for the repeated low?
Ans. No company-specific cause is confirmed by the available numbers. The price pattern is clear, but the data does not establish why Fischer Medical Ventures Ltd. has kept making fresh yearly lows.
How does Fischer Medical Ventures Ltd. look on valuation?
Ans. The stock trades at a P/E of 68.64 and a P/B of 4.4. Those ratios remain above the Trading sector medians even after the decline, so the stock still looks expensive versus its benchmark.
How do ROE and ROCE compare for Fischer Medical Ventures Ltd.?
Ans. ROE is 9.38% and ROCE is 12.27%. Both are above the sector medians, which suggests the company is generating better profitability and capital efficiency than the typical peer, even while the share price remains weak.
How does Fischer Medical Ventures Ltd. compare with peers?
Ans. Its market cap is Rs 2,065.31 crore, and its valuation is above several peers in the Trading group. The streak has not made the stock low-valued on peer-based measures, even though the share price has weakened.
What should investors monitor next in Fischer Medical Ventures Ltd. share price?
Ans. Investors should watch whether the stock holds above Rs 29.1 or resets the yearly low again. They should also track any new company update, because the repeated-low pattern is confirmed even though the reason behind it is not.
Recent Articles

Wheels India Ltd. (WHEELS) Share Price Near 52-Week High After 2.51% Rise
16 October 2026

Reliance Industries Share Price Falls 2.5% Despite Jio IPO Buzz: What Should Mukesh Ambani Stock Investors Do?
16 October 2026

Cyient DLM Share Price Crashes 19% After Q2 Results but Up 213% From 52-Week Low: Should You Buy? Check Target Prices
16 October 2026

PC Jeweller Share: 50% Returns in 6 Months! What Is Driving the Stock? Experts Give 3 Reasons to Buy | Target, Stop-Loss
16 October 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Wheels India Ltd. (WHEELS) Share Price Near 52-Week High After 2.51% Rise
Reliance Industries Share Price Falls 2.5% Despite Jio IPO Buzz: What Should Mukesh Ambani Stock Investors Do?
Cyient DLM Share Price Crashes 19% After Q2 Results but Up 213% From 52-Week Low: Should You Buy? Check Target Prices
PC Jeweller Share: 50% Returns in 6 Months! What Is Driving the Stock? Experts Give 3 Reasons to Buy | Target, Stop-Loss
AVANA ELECTROSYSTEMS LTD Hits Lower Circuit on NSE, 16 October 2026
Popular this week
Alka India Ltd. Hits Upper Circuit on BSE, 16 October 2026

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





